Related Experiment Video
Updated: Mar 24, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Hemoglobinopathies in the Çukurova Region and Neighboring Provinces
Sedefgul Yuzbasioglu Ariyurek1, Sule Menziletoglu Yildiz1, Ali Erdinc Yalin2
1a Department of Medical Services and Technics , Vocational School of Health Services, Çukurova University , Adana , Turkey.
Insights
This study mapped hemoglobin (Hb) mutations in Turkey's Çukurova region, identifying 1382 carriers. Abnormal Hbs were most common, followed by beta-thalassemia and alpha-thalassemia mutations.
Area of Science:
- Genetics and Molecular Biology
- Hematology
- Population Health
Background:
- Thalassemias and abnormal hemoglobins (Hbs) represent significant public health concerns globally.
- Understanding the regional mutation spectrum is crucial for developing targeted screening and management strategies.
- The Çukurova region's specific genetic landscape for these disorders was previously underexplored.
Purpose of the Study:
- To determine the mutation spectrum of thalassemias and abnormal hemoglobins in the Çukurova region and surrounding provinces.
- To contribute to the creation of a comprehensive mutation map for these hematological conditions.
- To establish the frequency of different Hb mutations within the studied population.
Main Methods:
- Analysis of 8135 samples from five Turkish provinces (Adana, Hatay, Mersin, Konya, Kayseri) between 1993 and 2014.
- Utilized complete blood cell counts, Hb typing via cellulose acetate electrophoresis and HPLC.
- Employed microarray, RFLP, ARMS, and gap-PCR for molecular determination of Hb mutations in extracted genomic DNA.
Main Results:
- Out of 8135 samples, 1382 (17%) were identified as carrying Hb mutations.
- Abnormal Hbs were the most frequent (59.7%), followed by beta-thalassemia (30.7%) and alpha-thalassemia (9.9%) mutations.
- Hb S was the most common abnormal Hb; IVS-I-110 (G>A) was the most frequent beta-thalassemia mutation, and the 3.7 kb deletion was the most common alpha-thalassemia mutation.
Conclusions:
- This study provides a detailed mutation spectrum for thalassemias and abnormal hemoglobins in the Çukurova region.
- The findings highlight the significant prevalence of these genetic blood disorders in the region.
- Establishing this mutation profile is vital for informing genetic counseling, carrier screening programs, and clinical management.
Abstract:
To contribute to the creation of a mutation map of the region, we aimed to determine the mutation spectrum of thalassemias and abnormal hemoglobins (Hbs) in the Çukurova region and surrounding provinces. In this study, a total of 8135 samples from Adana, Hatay, Mersin, Konya and Kayseri provinces between 1993 and 2014 were analyzed. Complete blood cell (CBC) counts and Hb typing were carried out using automatic cell counters, cellulose acetate membrane electrophoresis and high performance liquid chromatography (HPLC), respectively. For the molecular analyses, genomic DNA was extracted using both manual and automated DNA extraction devices. Determination of Hb mutations were done by microarray, restriction fragment length polymorphism (RFLP), amplification refractory mutation system (ARMS) and gap-polymerase chain reaction (gap-PCR) methodologies. Samples were analyzed for abnormal Hb and thalassemia mutations. Out of 8135 samples, 1382 were observed to be carrying Hb mutations. It was identified that 826 mutation carriers included abnormal Hbs with a frequency of 59.7%, 416 carriers included β-thalassemia (β-thal) mutations with a frequency of 30.7% and 136 carriers included α-thalassemia (α-thal) mutations with a frequency of 9.9%. In this study, the most frequently observed abnormal Hb in the region was Hb S [β6(A3)Glu→Val (GTG > GAG), HBB: c.20T > A], whereas the most commonly observed mutations were the IVS-I-110 (G > A) (HBB: c.93-21G > A) point mutation in β-thal and the 3.7 kb deletion in α-thal.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Multiple Allele Traits
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...